You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 HBsAg and anti-HCV prevalence in PWID in the EU/EEA

From: Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups

Country HBsAg Anti-HCV
Year Sample size Prevalence (95% CI) Study design Setting Year Sample size Prevalence (95% CI) Study design Setting
Austria    2013 48 31.3 (18.7–46.3) DT ODD
Croatia 2007 200 0.5 (0.0–2.8) SP PRI 2007 200 44 (37.0–51.2) SP PRI
Cyprus 2013 82 6.1 (2.0–13.7) DT DTC 2013 82 47.6 (36.4–58.9) DT DTC
Czech Republic    2013 1889 14.6 (13.1–16.3) DT NSP
Denmark    2008 223 52.5 (45.7–59.2) SP (UAT) ODD
Finland    2009 682 60.5 (56.8–64.3) SP (UAT) NSP
Greece 2013 1337 3.0 (2.2–4.1) DT DTC; LTS; OTH; PHL; PRI; STR; 2013 1309 68.1 (65.5–70.6) DT DTC; LTS; PHL; PRI; OTH STR;
Hungary 2011 664 0.5 (0.1–1.3) SP DTC, NSP 2011 652 24.1 (20.8–27.6) SP DTC; NSP
Ireland 2010 200 0.5 (0.0–2.8) SP PRI 2010 200 41.5 (34.6–48.7) SP PRI
Italy    2010 743 60.5 (56.8–64.0) DT DTC
Latvia 2013 562 2.1 (1.1–3.7) DT DTC 2013 522 70.1 (66.0–74.0) DT NSP
Malta    2013 109 13.8 (7.9–21.7) DT ANT; DTC; HTC; OHC; PHL; STI
Norway     2013 6342 63.0 (61.8–64.2) SP DTC
Portugal 2013 399 6.3 (4.1–9.1) DT DTC 2013 414 84.3 (80.4–87.7) DT DTC
Slovenia    2009 112 32.1 (23.6–41.6) DT DTC
United Kingdom    2013 3144 49.1 (47.4–50.9) SP (UAT) DTC; LTS; OTH; NSP
  1. Acronyms (study design): DT diagnostic testing, SP specific prevalence study, UAT unlinked anonymous testing
  2. Acronyms (setting): ANT Antenatal Clinics, DTC Drug Treatment Centres, HTC HIV Testing Centres, LTS Low Threshold Services, ODD Overdose Deaths, OHC Other Hospitals or Clinics, OTH Other, NSP Needle Exchange Programmes, PHL Public Health Laboratories, PRI Prisons, STI STI clinics, STR Street